Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine.
Yang J, Lee KW, Baek JY, Bae S, Lee YH, Kim H, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Park JB, Kim SH, Kim TJ, Kim DM, Ko JH. Yang J, et al. Among authors: lee kw, lee yh. Am J Transplant. 2023 Apr;23(4):565-572. doi: 10.1016/j.ajt.2022.12.022. Epub 2023 Jan 3. Am J Transplant. 2023. PMID: 36739177 Free PMC article.
Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?
Kim H, Yang JS, Ko JH, Lee M, Lee JY, Park S, Kim JW, Shin Y, Lee JM, Na YJ, Park BK, Kim H, Lee YH, Yang J, Huh K, Cho SY, Kang CI, Chung DR, Peck KR. Kim H, et al. Among authors: lee m, lee jy, lee yh, lee jm. Front Med (Lausanne). 2022 Oct 12;9:988559. doi: 10.3389/fmed.2022.988559. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314031 Free PMC article.
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections.
Yang J, Won G, Baek JY, Lee YH, Kim H, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Lee KW, Park JB, Yoon SE, Kim SJ, Kim WS, Yim MS, Kim K, Hyeon S, Kim BC, Lee YK, Ko JH. Yang J, et al. Among authors: lee kw, lee yh, lee yk. Front Immunol. 2023 Mar 2;14:1139980. doi: 10.3389/fimmu.2023.1139980. eCollection 2023. Front Immunol. 2023. PMID: 36936968 Free PMC article.
Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023.
Yang J, Hyeon S, Baek JY, Kang MS, Lee KY, Lee YH, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Won G, Lee HW, Kim K, Hwang I, Lee SY, Kim BC, Lee YK, Ko JH. Yang J, et al. Among authors: lee sy, lee yh, lee hw, lee ky, lee yk. J Korean Med Sci. 2023 Jul 10;38(27):e205. doi: 10.3346/jkms.2023.38.e205. J Korean Med Sci. 2023. PMID: 37431539 Free PMC article.
False-positive Aspergillus galactomannan immunoassay in the glucose component of total parenteral nutrition products.
Chong E, Ko J-H, Kim DR, Lee YH, Yang J, Kim H, Huh K, Kang C-I, Chung DR, Peck KR, Jeong IH, Kim TY, Huh HJ, Lee NY, Shin A, Kim Y-J, Sohn YM, Cho SY, Kang E-S. Chong E, et al. Among authors: lee ny, lee yh. Microbiol Spectr. 2023 Dec 12;11(6):e0167323. doi: 10.1128/spectrum.01673-23. Epub 2023 Oct 6. Microbiol Spectr. 2023. PMID: 37800931 Free PMC article.
Antimicrobial activity of ceftazidime-avibactam against KPC-2-producing Enterobacterales: a cross-combination and dose-escalation titration study with relebactam and vaborbactam.
Kang MS, Baek JY, Ko J-H, Cho SY, Lee KY, Lee YH, Yang J, Kim TY, Huh HJ, Lee NY, Huh K, Kang C-I, Chung DR, Peck KR. Kang MS, et al. Among authors: lee ny, lee yh, lee ky. Microbiol Spectr. 2024 Apr 30:e0034424. doi: 10.1128/spectrum.00344-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 38687076 Free article.
7,341 results